View Profile

Oscar Lopez-Franco

Traslacional Medicine Laboratory. Instituto de Ciencias de la Salud · Universidad Veracruzana

https://researchid.co/oscarlopez01
@uv.mx
40Scopus Publications

Biography

Dr. Óscar López-Franco is a Senior Research in University of Veracruz-México. Graduate in Biochemistry by Complutense University and Doctorate with Honours by Autonoma University (Madrid-Spain, 1998 and 2004, respectively). More than 20 years of research experience. During this time (from 1999 to 2013) he has worked in three laboratories: Renal and Vascular Research Group (Jimenez Diaz Foundation, Madrid, Spain); Cardiovascular Research Group and Biomedical Research Group, both in University of Glasgow, UK. Since 2014, he has led the group “Translational Medicine” in the Health Science Institute of the University of Veracruz. His research activities focus on the molecular mechanisms of immune renal, diabetes and atherosclerosis diseases, with special interest in Fc receptors, SOCS proteins, gene therapy and microRNAs. Working as part of a multidisciplinary groups composed of both scientist and clinicians has been invaluable in developing research projects.

Education

Graduate in Biochemistry by Complutense University (Madrid-Spain, 1998) Doctorate with Honours by Autonoma University (Madrid-Spain, 2004)

Recent Scopus Publications

  1. Opposing functions of miR-155-5p and Socs1 drive vascular inflammation in diabetes-accelerated atherosclerosis
    Cardiovascular Diabetology, 2026
  2. Ovarian influence on circadian and infradian modulation of nicotine-seeking in female mice
    Journal of Neuroendocrinology, 2026
  3. Ovarian Hormones and Addictive Behaviour Vulnerability: Insights From Preclinical Studies
    Addiction Biology, 2025
  4. Counter-regulatory RAS peptides: new therapy targets for inflammation and fibrotic diseases?
    Frontiers in Pharmacology, 2024
  5. A mutual regulatory loop between miR-155 and SOCS1 influences renal inflammation and diabetic kidney disease
    Molecular Therapy Nucleic Acids, 2023

Grants / Consultancy

None N/A

Links